UBS Group’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-538	Closed	-$2K	–	8976
2021 Q1	$2K	Hold	538	–	–	﹤0.01%	7672
2020 Q4	$3K	Buy	+538	New	+$3K	﹤0.01%	7026